The Beckley Foundation and the department of Psychopharmacology in Maastricht University are inviting individuals to participate in an online study

The study aims to explore the use of psychedelics as pain management options, with a particular focus on microdosing.

Microdosing, which involves taking small amounts of psychedelic substances, has been growing in popularity for its psychological benefits including enhanced mood, productivity and cognition.

The survey is a followup to The Beckley Foundation’s recent placebo-controlled trial showing that low doses of LSD “may provide a viable, non-addictive alternative for pain management”.

It was the first study to revisit the potential of LSD in pain management since prohibition was put in place in the 60s.

Due to the trial only including 24 participants though, The Beckley Foundation is looking to increase the value of the study by inviting people to take part in their online study. 

Anyone interested in participating in the survey can do so here.

Founded by Amanda Feilding in 1998, the Beckley Foundation which is a non-profit NGO, has been at the forefront of global drug policy reform and scientific research into psychoactive substances.

In June reports stated that The Beckley Foundation had spun off a for-profit endeavour, Beckley Psytech, and raised $3.8m.

Beckley Psytech works closely with The Beckley Foundation and will provide financial and technical support to help with the development of the foundation’s research. Beckley Psytech has pledged to donate a share of future revenues to fund the non-profit work of the Foundation.

It is unclear how The Beckley Foundation’s studies will contribute to Beckley Psytech, but it is encouraging to see a trusted name in the psychedelics space doing both research and development.